Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Multiple enzyme systems and structural proteins" refers to a broad and non-specific group of biological molecules that are affected by certain chemical agents, rather than a single defined therapeutic target. This classification typically applies to substances like heavy metals, antiseptics, or cross-linking agents that interact with common functional groups such as thiols or amines found throughout the proteome (StatPearls, NBK556035). Because these agents do not distinguish between specific pathways, they often cause widespread cellular disruption, including the inhibition of metabolic enzymes and the alteration of cytoskeletal or membrane proteins. For example, silver ions exert antimicrobial effects by binding to these groups, which disrupts essential metabolic enzymes and compromises the integrity of bacterial cell walls (PubMed, 23017226). While this multi-target approach can be effective for topical antimicrobial applications or sterilization, it generally lacks the precision required for modern systemic drug design. Consequently, this term is often used in toxicology or classical pharmacology to describe the pleiotropic effects of non-selective inhibitors (PubChem, Silver Nitrate). The lack of specificity often results in a narrow therapeutic index, limiting the use of such agents to localized or external applications.
Non-specific binding to and denaturation of various enzymes and structural proteins through interaction with functional groups like sulfhydryl, amino, and carboxyl groups.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple enzyme systems and structural proteins.